Controlled Study of the Use of Quetiapine Fumarate in the Treatment of Patients With Bipolar Depression
A Confirmatory Multicenter, Double-blind, Randomized, Placebo Controlled Study of the Use of Quetiapine Fumarate (SEROQUEL) in the Treatment of Patients With Bipolar Depression
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment
Enrollment
Phase
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States
- Research Site
-
-
Arizona
-
Scottsdale, Arizona, United States
- Research Site
-
-
California
-
Cerritos, California, United States
- Research Site
-
Garden Grove, California, United States
- Research Site
-
San Diego, California, United States
- Research Site
-
Torrance, California, United States
- Research Site
-
-
Florida
-
Jacksonville, Florida, United States
- Research Site
-
Maitland, Florida, United States
- Research Site
-
Orlando, Florida, United States
- Research Site
-
Winter Park, Florida, United States
- Research Site
-
-
Idaho
-
Boise, Idaho, United States
- Research Site
-
-
Illinois
-
Oak Brook, Illinois, United States
- Research Site
-
Overbrook Terrace, Illinois, United States
- Research Site
-
-
Louisiana
-
Shreveport, Louisiana, United States
- Research Site
-
-
Maryland
-
Baltimore, Maryland, United States
- Research Site
-
-
New Jersey
-
Clementon, New Jersey, United States
- Research Site
-
Moorestown, New Jersey, United States
- Research Site
-
-
New Mexico
-
Albuquerque, New Mexico, United States
- Research Site
-
-
New York
-
Brooklyn, New York, United States
- Research Site
-
New York, New York, United States
- Research Site
-
Staten Island, New York, United States
- Research Site
-
-
North Carolina
-
Raleigh, North Carolina, United States
- Research Site
-
-
Ohio
-
Cincinnati, Ohio, United States
- Research Site
-
Dayton, Ohio, United States
- Research Site
-
-
Oklahoma
-
Oklahoma City, Oklahoma, United States
- Research Site
-
-
Oregon
-
Portland, Oregon, United States
- Research Site
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States
- Research Site
-
Pittsburgh, Pennsylvania, United States
- Research Site
-
-
South Carolina
-
Charleston, South Carolina, United States
- Research Site
-
-
Tennessee
-
Memphis, Tennessee, United States
- Research Site
-
-
Texas
-
Austin, Texas, United States
- Research Site
-
Houston, Texas, United States
- Research Site
-
-
Utah
-
Salt Lake City, Utah, United States
- Research Site
-
-
Washington
-
Bellevue, Washington, United States
- Research Site
-
Kirkland, Washington, United States
- Research Site
-
Seattle, Washington, United States
- Research Site
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Provision of informed consent before enrollment and any study-specific procedures. Patients deemed incapable of providing written consent will not be enrolled in this study; outpatient status
Exclusion Criteria:
- More than 8 mood episodes in the past year from screen (visit 1);
- A current Axis I disorder other than bipolar disorder within 6 months of screening;
- patients with clinically significant abnormal laboratory findings in the investigator's judgment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Double
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
|---|
|
Change from baseline to week 8 in the Montgomery-Asberg Depression Rating Scale (MADRS) total score
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
|---|
|
Evaluate the incidence of treatment-emergent mania compared to placebo
|
Collaborators and Investigators
Sponsor
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Start
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- D1447C00135
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.